Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
NCT07503613
·
clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Vestibular Schwannoma
Sponsor
Akouos, Inc.
Collaborators
[object Object]